<bill session="117" type="s" number="3656" updated="2023-05-22T19:30:30Z">
  <state datetime="2022-02-16">REFERRED</state>
  <status>
    <introduced datetime="2022-02-16"/>
  </status>
  <introduced datetime="2022-02-16"/>
  <titles>
    <title type="display">Reducing Hereditary Cancer Act of 2022</title>
    <title type="short" as="introduced">Reducing Hereditary Cancer Act of 2022</title>
    <title type="official" as="introduced">A bill to amend title XVIII of the Social Security Act to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer.</title>
  </titles>
  <sponsor bioguide_id="M001153"/>
  <cosponsors>
    <cosponsor bioguide_id="C000141" joined="2022-02-16"/>
    <cosponsor bioguide_id="K000383" joined="2022-07-14"/>
    <cosponsor bioguide_id="V000128" joined="2022-07-12"/>
  </cosponsors>
  <actions>
    <action datetime="2022-02-16">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2022-02-16" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="4110" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Cancer"/>
    <term name="Genetics"/>
    <term name="Health care coverage and access"/>
    <term name="Health promotion and preventive care"/>
    <term name="Hereditary and development disorders"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Medicare"/>
  </subjects>
  <amendments/>
  <summary date="2022-02-23T22:30:02Z" status="Introduced in Senate">Reducing Hereditary Cancer Act of 2022

This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.</summary>
</bill>
